1-7 of 7
Juliana Velez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Sustained Responses Following Ibrutinib Discontinuation after Frontline Therapy with Obinutuzumab Plus Ibrutinib in Patients with Chronic Lymphocytic Leukemia

Paula A. Lengerke Diaz, MD, Michael Y. Choi, MD, Eider F. Moreno Cortes, MD, Jose V. Forero, MD, Juliana Velez-Lujan, PhD, Carlos I. Amaya-Chanaga, MD, Thomas Kipps, MDPhD, Januario E. Castro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-143473
Published: 2020
Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Juliana Velez Lujan, BS,PhD, Michael Y. Choi, MD, Chaja Jacobs, MD, Colin McCarthy, BS, Alaina Heinen, BS, Carlos Amaya-Chanaga, MD, Thomas J. Kipps, MD PhD, Januario E Castro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1863.
https://doi.org/10.1182/blood-2018-99-118990
Published: 2018
Journal Articles

Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma Cytokine Levels

Juliana Velez Lujan, BS,PhD, Chaja Jacobs, MD, Paula A Lengerke Diaz, MD, Eider F Moreno-Cortes, MD, Cesar A Ramirez-Segura, BS, PhD, Michael Y. Choi, MD, Colin McCarthy, BS, Alaina Heinen, BS, Carlos Amaya-Chanaga, MD, Thomas J. Kipps, MD PhD, Januario E Castro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1864.
https://doi.org/10.1182/blood-2018-99-119523
Published: 2018
Journal Articles

Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) Combination for Patients with Chronic Lymphocytic Leukemia (CLL) - a Phase Ib/II Study

Januario E Castro, MD, Carlos I. Amaya-Chanaga, MD, Juliana Velez Lujan, BS,PhD, Michael Choi, MD, Colin McCarthy, BS, Thomas J. Kipps, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1730.
https://doi.org/10.1182/blood.V130.Suppl_1.1730.1730
Published: 2017
Journal Articles

Role of Glutamine in Metabolic and Epigenetic Reprogramming in AML

Juliana Vélez Luján, PhDCandidate, Niki Zacharias, PhD, Dinesh Rakheja, MD, Tushar D Bhagat, PhD, Jaehyuk Lee, PhD, Prasanta Dutta, PhD, Doriann Gonzalez, MDStudent, Michael Andreeff, MD PhD, Pratip K Bhattacharya, PhD, Amit Verma, M.B.,B.S., Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2559.
https://doi.org/10.1182/blood.V126.23.2559.2559
Published: 2015
Journal Articles

Novel Nanomolar Potency Mitochondrial Complex I Inhibitor Iacs-1131 Selectively Kills Oxphos-Dependent AML Cells

Polina Matre, PhD, Marina Protopopova, Ningping Feng, Jason Gay, Jennifer Greer, Juliana Velez, Hong Mu, MD PhD, Alessia Lodi, Surendar Tadi, Shannon Sweeney, Michael Andreeff, MD PhD, Stefano Tiziani, M. Emilia DiFrancesco, Joseph Marszalek, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 622.
https://doi.org/10.1182/blood.V124.21.622.622
Published: 2014
Journal Articles

Efficacy of Novel Glutaminase Inhibitor CB-839 in Acute Myeloid Leukemia

Polina Matre, PhD, Maryam Shariati, Juliana Velez, Yuan Qi, Sergej Konoplev, MD PhD, Xiaoping Su, PhD, Courtney D. DiNardo, MD, Naval Daver, MD, Ravi Majeti, MD PhD, Michael Andreeff, MD PhD, Steven M. Chan, MD PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3763.
https://doi.org/10.1182/blood.V124.21.3763.3763
Published: 2014